CHAI&Gavi：2025年新型结核疫苗全球需求预测：早期规划与需求评估情景分析报告（英文版）

Tuberculosis (TB) remains the leading infectious disease worldwide, causing 10.8 million cases and 1.3 million deaths in 2023, with 90% of the burden concentrated in low- and middleincome countries. While current prevention tools are inadequate to effectively eliminate TB, novel TB vaccines for adolescents and adults are currently in advanced clinical trials with early modelling suggesting that such vaccines could significantly reduce TB incidence and mortality. Following the Gavi Board’s 202